C4 Therapeutics Inc
CCCC
$2.75-1.08%
Delayed · as of Oct 16, 2026, 3:45 PM ET
Mkt cap
$425.68M
EV/Sales
9.77
P/E ratio
N/A
FY2025 Revenue
$35.95M
EPS (TTM)
$-1.24
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-292.08%
Beta
2.78
Div yield
N/A
Sector
Healthcare
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Latest reported CCCC revenue for 2025-12-31 was $35.9M. Net income was -$105.0M. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. CCCC currently screens at market cap $425.7M.
Use this CCCC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CCCC income, balance, and cash tables.
C4 Therapeutics Inc (CCCC) is a biotechnology company in the Healthcare sector.
Latest cached C4 Therapeutics Inc (CCCC) revenue for Dec 31, 2025 was $35.9M. Net income was -$105.0M. Statements: https://lician.com/financials/cccc
C4 Therapeutics Inc (CCCC) market capitalization is $425.7M on the latest cached snapshot.
C4 Therapeutics Inc (CCCC) cached previous close $2.78; day range $2.75 – $2.78; volume 1,791,138. Session quote: https://lician.com/quote/cccc
C4 Therapeutics Inc (CCCC) latest cached earnings event is "CCCC earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CCCC filing is 8-K · Sep 25, 2026. Filings: https://lician.com/sec/cccc